1.Age-related changes in seminal polymorphonuclear elastase in men with asymptomatic inflammation of the genital tract.
Ralf HENKEL ; Gesa MAASS ; Andreas JUNG ; Gerhard HAIDL ; Wolf-Bernhard SCHILL ; Hans-Christian SCHUPPE
Asian Journal of Andrology 2007;9(3):299-304
AIMTo investigate age-related inflammatory events in the male genital tract.
METHODSIn a total of 4265 randomly collected patients attending the andrological outpatient clinic of the Center for Dermatology and Andrology, University of Giessen, Germany, ejaculate volume, pH-value, sperm concentration, total and progressive sperm motility, concentration of polymorphonuclear (PMN) elastase, number of peroxidase-positive cells and fructose were measured and correlated with patient's age.
RESULTSWhile ejaculate volume, motility and fructose all correlated negatively with age, sperm concentration, PMN elastase and the pH-value showed a positive correlation. The prevalence of male genital tract inflammation (as defined by PMN elastase > 250 ng/mL) and its severity increased significantly. PMN elastase did not correlate with sperm motility. Fructose as a marker of seminal vesicle function showed a significant negative relationship with the PMN elastase levels, the number of peroxidase-positive cells and sperm motility.
CONCLUSIONThe significant increases of PMN-elastase levels as marker of male genital tract inflammation in older men appear to be indicative of age-related changes in local immunoregulatory mechanisms. Because there is no association of PMN elastase with sperm motility, a direct inhibitory effect of this enzyme can be excluded.
Adolescent ; Adult ; Aged ; Aging ; physiology ; Biomarkers ; metabolism ; Ejaculation ; Genital Diseases, Male ; enzymology ; pathology ; Humans ; Infertility, Male ; enzymology ; pathology ; Inflammation ; enzymology ; pathology ; Leukocyte Elastase ; metabolism ; Male ; Middle Aged ; Retrospective Studies ; Semen ; cytology ; enzymology ; physiology ; Sperm Count
2.The Expression of Thymidine Phosphorylase in Cancer-infiltrating Inflammatory Cells in Stomach Cancer.
Joung Soon JANG ; Won Sup LEE ; Jong Seok LEE ; Hwal Woong KIM ; Gyung Hyuck KO ; Woo Song HA
Journal of Korean Medical Science 2007;22(Suppl):S109-S114
Thymidine phosphorylase (TP) has shown to be up-regulated in several cancers and to play a role in angiogenesis and invasion. Most studies regarding TP have focused on cancer cells. Recently, evidences suggest that TP in cancer-infiltrating inflammatory cells (CIICs) also affect the cancer cell behavior. To evaluate the significance of TP expression of CIICs in gastric cancer, we assessed TP expression of cancer cells and CIICs separately using immunohistochemical assay on 116 paraffin-embedded tissue samples from stomach cancer patients and investigated their clinical significance. When subjects were divided into 4 groups according to the TP expression: cancer/matrix (+/+), C/M (+/-), C/M (-/+), and C/M (-/-), intratumoral microvessel density scores were higher in the C/M (+/-) group than in the C/M (-/-) group (p=0.02). For lymph node metastasis and survival, there were no significant differences among the 4 groups. However, there were significant differences in survival (p=0.035) and LN metastasis (p=0.023) between the two groups divided by TP expression of CIICs alone irrespective of TP expression of cancer cells. Taken together, this study suggested the TP expression in CIICs could affect lymph node metastasis and patients' survival in gastric cancer.
Adult
;
Aged
;
Female
;
Humans
;
Immunohistochemistry
;
Inflammation/*enzymology/pathology
;
Kaplan-Meiers Estimate
;
Lymphatic Metastasis
;
Lymphocytes, Tumor-Infiltrating/*enzymology/pathology
;
Male
;
Microcirculation/pathology
;
Middle Aged
;
Neovascularization, Pathologic
;
Prognosis
;
Stomach Neoplasms/blood supply/*enzymology/mortality/pathology
;
Thymidine Phosphorylase/*metabolism
3.Over-expression of extracellular superoxide dismutase in mouse synovial tissue attenuates the inflammatory arthritis.
Dong Hoon YU ; Jun Koo YI ; Hyung Soo YUH ; Seo jin PARK ; Hei Jung KIM ; Ki Beom BAE ; Young Rae JI ; Na Ri KIM ; Si Jun PARK ; Do Hyung KIM ; Sung Hyun KIM ; Myoung Ok KIM ; Jeong Woong LEE ; Zae Young RYOO
Experimental & Molecular Medicine 2012;44(9):529-535
Oxidative stress such as reactive oxygen species (ROS) within the inflamed joint have been indicated as being involved as inflammatory mediators in the induction of arthritis. Correlations between extracellular-superoxide dismutase (EC-SOD) and inflammatory arthritis have been shown in several animal models of RA. However, there is a question whether the over-expression of EC-SOD on arthritic joint also could suppress the progression of disease or not. In the present study, the effect on the synovial tissue of experimental arthritis was investigated using EC-SOD over-expressing transgenic mice. The over-expression of EC-SOD in joint tissue was confirmed by RT-PCR and immunohistochemistry. The degree of the inflammation in EC-SOD transgenic mice was suppressed in the collagen-induced arthritis model. In a cytokine assay, the production of pro-inflammatory cytokines such as, IL-1beta, TNFalpha, and matrix metalloproteinases (MMPs) was decreased in fibroblast-like synoviocyte (FLS) but not in peripheral blood. Histological examination also showed repressed cartilage destruction and bone in EC-SOD transgenic mice. In conclusion, these data suggest that the over-expression of EC-SOD in FLS contributes to the activation of FLS and protection from joint destruction by depressing the production of the pro-inflammatory cytokines and MMPs. These results provide EC-SOD transgenic mice with a useful animal model for inflammatory arthritis research.
Animals
;
Arthritis, Experimental/blood/*enzymology/metabolism
;
*Arthritis, Rheumatoid/enzymology/pathology
;
Fibroblasts/metabolism
;
Gene Expression Regulation
;
Inflammation/pathology
;
Interleukin-1beta/blood/metabolism
;
Joints/enzymology/pathology
;
Matrix Metalloproteinases/blood/metabolism
;
Mice
;
Mice, Transgenic
;
Reactive Oxygen Species/metabolism
;
*Superoxide Dismutase/genetics/metabolism
;
Synovial Fluid/*enzymology
;
Synovial Membrane/pathology
4.Protease and Protease-Activated Receptor-2 Signaling in the Pathogenesis of Atopic Dermatitis.
Sang Eun LEE ; Se Kyoo JEONG ; Seung Hun LEE
Yonsei Medical Journal 2010;51(6):808-822
Proteases in the skin are essential to epidermal permeability barrier homeostasis. In addition to their direct proteolytic effects, certain proteases signal to cells by activating protease-activated receptors (PARs), the G-protein-coupled receptors. The expression of functional PAR-2 on human skin and its role in inflammation, pruritus, and skin barrier homeostasis have been demonstrated. Atopic dermatitis (AD) is a multifactorial inflammatory skin disease characterized by genetic barrier defects and allergic inflammation, which is sustained by gene-environmental interactions. Recent studies have revealed aberrant expression and activation of serine proteases and PAR-2 in the lesional skin of AD patients. The imbalance between proteases and protease inhibitors associated with genetic defects in the protease/protease inhibitor encoding genes, increase in skin surface pH, and exposure to proteolytically active allergens contribute to this aberrant protease/PAR-2 signaling in AD. The increased protease activity in AD leads to abnormal desquamation, degradation of lipid-processing enzymes and antimicrobial peptides, and activation of primary cytokines, thereby leading to permeability barrier dysfunction, inflammation, and defects in the antimicrobial barrier. Moreover, up-regulated proteases stimulate PAR-2 in lesional skin of AD and lead to the production of cytokines and chemokines involved in inflammation and immune responses, itching sensation, and sustained epidermal barrier perturbation with easier allergen penetration. In addition, PAR-2 is an important sensor for exogenous danger molecules, such as exogenous proteases from various allergens, and plays an important role in AD pathogenesis. Together, these findings suggest that protease activity or PAR-2 may be a future target for therapeutic intervention for the treatment of AD.
Anti-Infective Agents/pharmacology
;
Dermatitis, Atopic/*enzymology
;
Endopeptidases/metabolism
;
Homeostasis
;
Humans
;
Hydrogen-Ion Concentration
;
Inflammation
;
Models, Biological
;
Models, Genetic
;
Peptide Hydrolases/*metabolism
;
Receptor, PAR-2/*metabolism
;
Serine Proteases/metabolism
;
Signal Transduction
;
Skin/enzymology/pathology
;
Treatment Outcome
5.Inhibition of Janus activated kinase-3 protects against myocardial ischemia and reperfusion injury in mice.
Young Bin OH ; Min AHN ; Sang Myeong LEE ; Hyoung Won KOH ; Sun Hwa LEE ; Suhn Hee KIM ; Byung Hyun PARK
Experimental & Molecular Medicine 2013;45(5):e23-
Recent studies have documented that Janus-activated kinase (JAK)-signal transducer and activator of transcription (STAT) pathway can modulate the apoptotic program in a myocardial ischemia/reperfusion (I/R) model. To date, however, limited studies have examined the role of JAK3 on myocardial I/R injury. Here, we investigated the potential effects of pharmacological JAK3 inhibition with JANEX-1 in a myocardial I/R model. Mice were subjected to 45 min of ischemia followed by varying periods of reperfusion. JANEX-1 was injected 1 h before ischemia by intraperitoneal injection. Treatment with JANEX-1 significantly decreased plasma creatine kinase and lactate dehydrogenase activities, reduced infarct size, reversed I/R-induced functional deterioration of the myocardium and reduced myocardial apoptosis. Histological analysis revealed an increase in neutrophil and macrophage infiltration within the infarcted area, which was markedly reduced by JANEX-1 treatment. In parallel, in in vitro studies where neutrophils and macrophages were treated with JANEX-1 or isolated from JAK3 knockout mice, there was an impairment in the migration potential toward interleukin-8 (IL-8) and monocyte chemoattractant protein-1 (MCP-1), respectively. Of note, however, JANEX-1 did not affect the expression of IL-8 and MCP-1 in the myocardium. The pharmacological inhibition of JAK3 might represent an effective approach to reduce inflammation-mediated apoptotic damage initiated by myocardial I/R injury.
Animals
;
Apoptosis/drug effects
;
Cell Movement/drug effects
;
Chemokines/pharmacology
;
Heart Function Tests/drug effects
;
Inflammation/pathology
;
Janus Kinase 3/*antagonists & inhibitors/metabolism
;
Macrophages/drug effects/metabolism/pathology
;
Male
;
Mice
;
Mice, Inbred C57BL
;
Myocardial Reperfusion Injury/drug therapy/*enzymology/physiopathology/*prevention & control
;
Myocardium/enzymology/pathology
;
Myocytes, Cardiac/drug effects/metabolism/pathology
;
Neutrophils/drug effects/metabolism/pathology
;
Quinazolines/pharmacology/therapeutic use
6.Rebamipide-induced downregulation of phospholipase D inhibits inflammation and proliferation in gastric cancer cells.
Dong Woo KANG ; Gyesik MIN ; Do Yoon PARK ; Ki Whan HONG ; Do Sik MIN
Experimental & Molecular Medicine 2010;42(8):555-564
Rebamipide a gastroprotective drug, is clinically used for the treatment of gastric ulcers and gastritis, but its actions on gastric cancer are not clearly understood. Phospholipase D (PLD) is overexpressed in various types of cancer tissues and has been implicated as a critical factor in inflammation and carcinogenesis. However, whether rebamipide is involved in the regulation of PLD in gastric cancer cells is not known. In this study, we showed that rebamipide significantly suppressed the expression of both PLD1 and PLD2 at a transcriptional level in AGS and MKN-1 gastric cancer cells. Downregulation of PLD expression by rebamipide inhibited its enzymatic activity. In addition, rebamipide inhibited the transactivation of nuclear factor kappa B (NFkappaB), which increased PLD1 expression. Rebamipide or PLD knockdown significantly suppressed the expression of genes involved in inflammation and proliferation and inhibited the proliferation of gastric cancer cells. In conclusion, rebamipide-induced downregulation of PLD may contribute to the inhibition of inflammation and proliferation in gastric cancer.
Alanine/*analogs & derivatives/pharmacology
;
Cell Line, Tumor
;
Cell Proliferation/drug effects
;
Down-Regulation/*drug effects
;
Gene Expression Regulation, Neoplastic/*drug effects
;
Humans
;
Inflammation/*enzymology/genetics/pathology
;
Isoenzymes/genetics/metabolism
;
NF-kappa B/metabolism
;
Phospholipase D/*genetics/metabolism
;
Promoter Regions, Genetic/genetics
;
Quinolones/*pharmacology
;
Stomach Neoplasms/*enzymology/genetics/*pathology
;
Transcription, Genetic/drug effects
7.Effects of recombinant sCR1 on the immune inflammatory reaction in acute spinal cord injury tissue of rats.
Liang-man LI ; Yue ZHU ; Guang-yu FAN
Chinese Journal of Traumatology 2005;8(1):49-53
OBJECTIVETo determine the effects of recombinant soluble complement receptor type I (sCR1) on the immune inflammatory reaction in acute spinal cord injury tissue of rats and its protective effects.
METHODSSD rat models of acute spinal cord injury were prepared by modified Allen's method. The motor function of the rat lower extremities in sCR1 group and normal saline (NS) group was evaluated by the tiltboard experiment at 12 h, 1 d, 3 d, 7 d, and 14 d. The neutrophil infiltration and C3c positive expression were observed. The myeloperoxidase activity was assessed in the injury tissue at 12 h, 1 d, 3 d, 7 d, and 14 d after injury in the two groups.
RESULTSThe motor function of rat in sCR1 group at 3 d, 7 d, and 14 d was obviously better than that in NS group (P<0.01, P<0.01, P<0.01). C3c positive expression in sCR1 group at each time point after injury was obviously less than that in NS group (P<0.01). The myeloperoxidase activity in sCR1 group at each time point after injury was obviously less than that in NS group (P<0.01).
CONCLUSIONSRecombinant soluble complement receptor type I (sCR1) can lessen the immune inflammatory reaction in acute spinal cord injury tissue and relieve secondary spinal cord injury by inhibiting the activation of the complement system.
Animals ; Disease Models, Animal ; Immunohistochemistry ; Inflammation ; Peroxidase ; biosynthesis ; Random Allocation ; Rats ; Rats, Sprague-Dawley ; Receptors, Complement ; therapeutic use ; Recombinant Proteins ; therapeutic use ; Spinal Cord Injuries ; drug therapy ; enzymology ; pathology
8.Parasitic Helminth Cystatin Inhibits DSS-Induced Intestinal Inflammation Via IL-10+F4/80+ Macrophage Recruitment.
Sung Won JANG ; Min Kyoung CHO ; Mi Kyung PARK ; Shin Ae KANG ; Byoung Kuk NA ; Soon Cheol AHN ; Dong Hee KIM ; Hak Sun YU
The Korean Journal of Parasitology 2011;49(3):245-254
Many immune down-regulatory molecules have been isolated from parasites, including cystatin (cystain protease inhibitor). In a previous study, we isolated and characterized Type I cystatin (CsStefin-1) of the liver fluke, Clonorchis sinensis. To investigate whether the CsStefin-1 might be a new host immune modulator, we induced intestinal inflammation in mice by dextran sodium sulfate (DSS) and treated them with recombinant CsStefin-1 (rCsStefin-1). The disease activity index (DAI) increased in DSS only-treated mice. In contrast, the DAI value was significantly reduced in rCsStefin-1-treated mice than DSS only-treated mice. In addition, the colon length of DSS only-treated mice was shorter than that of rCsStefin-1 treated mice. The secretion levels of IFN-gamma and TNF-alpha in the spleen and mesenteric lymph nodes (MLNs) were significantly increased by DSS treatment, but the level of TNF-alpha in MLNs was significantly decreased by rCsStefin-1 treatment. IL-10 production in both spleen and MLNs was significantly increased, and IL-10+F4/80+ macrophage cells were significantly increased in the spleen and MLNs of rCsStefin-1 treated mice after DSS treatment. In conclusion, rCsStefin-1 could reduce the intestinal inflammation occurring after DSS treatment, these effects might be related with recruitment of IL-10 secreting macrophages.
Animals
;
Antigens, Differentiation/analysis
;
Clonorchis sinensis/*enzymology
;
Colon/pathology
;
Cystatins/*metabolism
;
Cytokines/secretion
;
Dextran Sulfate/toxicity
;
Female
;
Helminth Proteins/*metabolism
;
Immunologic Factors/*metabolism
;
Inflammation/chemically induced/*pathology
;
Interleukin-10/analysis
;
Intestines/*drug effects/pathology
;
Lymph Nodes/immunology
;
Macrophages/chemistry/*immunology
;
Mice
;
Mice, Inbred C57BL
;
Severity of Illness Index
;
Spleen/immunology
9.Sphingomyelin synthase 2 deficiency decreases atherosclerosis and inhibits inflammation in mice.
Rui QIN ; Ming-Liang CHEN ; Ke ZHU ; Jin-Bo DENG ; Yuan-Yuan SHI
Acta Physiologica Sinica 2010;62(4):333-338
Plasma sphingomyelin (SM) has been shown to be an independent risk factor for coronary heart disease, and sphingomyelin synthase 2 (SMS2) contributes to de novo SM biosynthesis and plasma membrane SM levels. The aim of the present study is to evaluate the in vivo role of SMS2 deficiency in serum SM metabolism and atherosclerosis (AS) development. We used male SMS2 knockout (SMS2(-/-)) and C57BL/6J (wild-type, WT) mice as experimental and control groups, respectively. Each group was fed high-fat diet (1% cholesterol, 20% leaf fat), as well as bile salt for accelerating the atherosclerotic formation. After three months of feeding, the mice were killed to observe aortic arches and oil red-stained longitudinal sections of thoracoabdominal aortae. Fasting blood samples were taken from the tail vein before and after high-fat diet, and the serum lipid and SM levels were measured by using kits and enzymatic method respectively. Western blot was used to analyze the contents of nuclear factor-kappaB (NFkappaB) p65 subunit in peritoneal macrophages stimulated with lipopolysaccharide (LPS) after high-fat diet. The results showed that after high-fat diet, SMS2(-/-) mice presented decreased atherosclerotic lesions in aortic arch and thoracoabdominal aorta compared with WT mice. Regardless of whether high-fat diet were given or not, SMS2(-/-) mice showed a significant decrease in serum SM level (P<0.05), but no significant changes in serum lipid levels, compared with WT mice. The expressions of NFkappaB p65 were attenuated in macrophages from SMS2(-/-) mice in response to LPS stimulation compared with those of the WT mice. These results suggest that SMS2 deficiency decreases AS and inhibits inflammation in mice. Thus, SMS2 deficiency may be a potential therapeutic strategy.
Animals
;
Aorta
;
pathology
;
Atherosclerosis
;
metabolism
;
physiopathology
;
prevention & control
;
Diet, High-Fat
;
Dietary Fats
;
administration & dosage
;
Gene Knockout Techniques
;
Inflammation
;
prevention & control
;
Macrophages, Peritoneal
;
enzymology
;
pathology
;
Male
;
Mice
;
Mice, Inbred C57BL
;
Mice, Knockout
;
NF-kappa B
;
metabolism
;
Sphingomyelins
;
blood
;
Transferases (Other Substituted Phosphate Groups)
;
genetics
10.Effect of Chinese herbal medicine for activating blood circulation and detoxifying on expression of inflammatory reaction and tissue damage related factors in experimental carotid artery thrombosis rats.
Mei XUE ; Lu ZHANG ; Lin YANG ; Yue-rong JIANG ; Chun-yu GUO ; Hui-jun YIN ; Ke-ji CHEN
Chinese journal of integrative medicine 2010;16(3):247-251
OBJECTIVETo observe the pharmaceutical effect of Chinese drugs for activating blood circulation (Xiongshao Capsule, XSC, ) and for activating blood circulation and detoxification (Xiongshao Capsule and Huanglian Capsule, XSHLC, ) in terms of the indices of thrombosis, inflammatory reaction and tissue damage related factors in experimental carotid artery thrombosis rats.
METHODSFifty Wistar rats were randomly divided into the sham operation group, the model group, the Simvastatin group (SG), the activating blood circulation (ABC) group, and the activating blood circulation and detoxifying (ABCD) group, with 10 rats in each group. Simvastatin (1.8 mg/kg), XSC (0.135 g/kg) and XSHLC (0.135 g/kg) were administered to Simvastatin, ABC and ABCD group by gastrogavage, and an equal volume of normal saline was given to the sham operation group and the model group. After 2 weeks of successive medication, the rats in the model and all drug therapy groups were made into experimental carotid artery thrombosis model. The serum levels of matrix metalloproteinases (MMP-9), tissue inhibitors to metalloproteinase (TIMP-1), granule membrane protein-140 (GMP-140), tissue-type plasminogen activator (t-PA), high-sensitivity C-reactive protein (hs-CRP) and interleukin-6 (IL-6) were detected with enzyme-linked immunoassay 24 h later.
RESULTSCompared with the model group, the levels of serum GMP-140, hs-CRP, IL-6 and MMP-9 were significantly decreased, and the level of t-PA was significantly increased in the ABC and ABCD group ( P<0.05), while the level of serum hs-CRP in ABCD group decreased significantly compared with that in the ABC group (P<0.05).
CONCLUSIONSChinese drugs both for activating blood circulation and for activating blood circulation and detoxifying have good effects on regulating indices of thrombosis, inflammatory reaction and tissue damage in experimental carotid artery thrombosis rats. The effect of activating blood circulation and detoxifying drugs on regulating the level of serum hs-CRP is superior to that of activating blood circulation drug alone.
Animals ; Biomarkers ; blood ; Blood Circulation ; drug effects ; C-Reactive Protein ; metabolism ; Carotid Artery Thrombosis ; drug therapy ; enzymology ; pathology ; physiopathology ; Carotid Artery, Common ; pathology ; Drugs, Chinese Herbal ; pharmacology ; therapeutic use ; Female ; Inflammation ; blood ; complications ; Interleukin-6 ; blood ; Male ; Matrix Metalloproteinase 9 ; blood ; P-Selectin ; blood ; Rats ; Rats, Wistar ; Tissue Inhibitor of Metalloproteinase-1 ; blood ; Tissue Plasminogen Activator ; blood